Gary W. Falk
Falk, Gary W., 19..-....
Falk, Gary W.
VIAF ID: 209078419 (Personal)
Permalink: http://viaf.org/viaf/209078419
Preferred Forms
-
- 100 1 _ ‡a Falk, Gary W. ‡d 19..-...
- 100 1 _ ‡a Falk, Gary W., ‡d 19..-....
- 100 0 _ ‡a Gary W. Falk
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Biologics of IBD | |
BMP-driven NRF2 activation in esophageal basal cell differentiation and eosinophilic esophagitis | |
Chemoprevention and Barrett's esophagus: decisions, decisions | |
Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett’s esophagus | |
Control of acid and duodenogastroesophageal reflux | |
A coxib a day won't keep the doctor away | |
A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. | |
Cutting to the chase: circumferential endoscopic mucosal resection for Barrett's neoplasia | |
Effect of ozone and nitrogen dioxide on the agglutination of rat alveolar macrophages by concanavalin A. | |
Eosinophilic esophagitis: New insights into an emerging disease | |
Eosinophilic esophagitis: updated consensus recommendations for children and adults | |
Eosinophilic pancreatitis presenting as a pancreatic mass with obstructive jaundice | |
Erratum: Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia | |
Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial | |
Esophageal epithelial cells acquire functional characteristics of activated myofibroblasts after undergoing an epithelial to mesenchymal transition | |
Esophageal manometry: assessment of interpreter consistency | |
Evidence for DNA damage checkpoint activation in barrett esophagus | |
Fluorescence in situ hybridization of cytologic specimens from Barrett's esophagus: a pilot feasibility study | |
Gastric and Esophageal pH in Patients With Barrett's Esophagus Treated With Three Esomeprazole Dosages: A Randomized, Double-Blind, Crossover Trial | |
Gastroparesis. | |
Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection | |
Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. | |
Inhibition of transient lower esophageal sphincter relaxation in GERD: will lesogaberan advance the field? | |
Is conventional endoscopic identification of non-erosive reflux disease adequate? | |
Is FDG-PET indicated for superficial esophageal cancer?☆ | |
Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia | |
Laryngopharyngeal Reflux: Beauty is in The Eye of The Beholder | |
Location, location, location: does early cancer in Barrett's esophagus have a preference? | |
Management of early-stage esophageal neoplasia (MESEN) consensus | |
Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus. | |
Modeling inflammation and oxidative stress in gastrointestinal disease development using novel organotypic culture systems | |
Motility and GI function studies billing and coding guidelines: a position paper of the American Motility Society. | |
The natural history of eosinophilic oesophagitis in the transition from childhood to adulthood. | |
Night Vision Goggles for Surveillance of Barrett’s Esophagus: A Paradigm Shift is Coming! | |
Observer variation and reproducibility of endoscopic ultrasonography. | |
p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression. | |
Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. | |
Poor discriminatory function for endoscopic skills on a computer-based simulator | |
Probe-based confocal endomicroscopy in Barrett's esophagus: the real deal or another tease? | |
Radiofrequency ablation for Barrett's esophagus | |
Refractory GERD: Further Insights Into the Cause of Symptoms | |
The Role of Allergy Evaluation in Adults With Eosinophilic Esophagitis | |
Role of barium esophagography in evaluating dysphagia | |
Role ofHelicobacter pylori cagA+ strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia | |
The Seattle Protocol Does Not More Reliably Predict the Detection of Cancer at the Time of Esophagectomy Than a Less Intensive Surveillance Protocol | |
The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. | |
Should wheat, barley, rye, and/or gluten be avoided in a 6-food elimination diet? | |
Subsquamous intestinal metaplasia: implications for endoscopic management of Barrett's esophagus | |
Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders. | |
Superficial adenocarcinoma of the esophagus | |
Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology | |
T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis. | |
Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. | |
Turning an idea into a grant | |
An Unusual Cause of Abdominal Pain. Appendiceal Intussusception Owing to Cecal Adenocarcinoma. | |
An update on esophageal diseases | |
Upper GI Bleeding | |
Variation in age at cancer diagnosis in familial versus nonfamilial Barrett's esophagus | |
Why is esophageal adenocarcinoma increasing in incidence? |